Skip to content

Management of Essential Hypertension with Ayurvedic Herbal Medicines and its computational analysis

A Comparative Insilico & Clinical Study to Design and Assess the Efficacy of Potential Ayurvedic Drugs in the Management of Essential Hypertension

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070973
Enrollment
120
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of Essential Hypertension / Stage I Hypertension. 2.Patients between the age group of 30-65 years. 3.Patients suffering from Stage I Hypertension.

Exclusion criteria

Exclusion criteria: 1.Patients of Secondary Hypertension. 2.patients with any other comorbities e.g. Diabetes Mellitus, thyroid disorders, CCF, Multiorgan failure.

Design outcomes

Primary

MeasureTime frame
To assess the In-silico binding of Drug ligands on Protein Aminopeptidase A by the process of Molecular Docking.To assess the efficacy of selected compounds on the patients of Essential Hypertension.To assess the efficacy of Gomutra bhavit selected compounds on the patients of Essential Hypertension.To compare the effect of selected compounds and Gomutra bhavit selected compounds and modern treatment regimen.Timepoint: 6weeks

Secondary

MeasureTime frame
To compare the effect of selected compounds and Gomutra bhavit selected compounds and modern treatment regimen.Timepoint: 3 month

Countries

India

Contacts

Public ContactProf O P Singh

Dept of Kayachikitsa FoAy IMS Banaras Hindu University

yadav292pooja@gmail.com9916066068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026